LakeShore Biopharma Co Ltd [NASDAQ: LSB] gained 40.74% on the last trading session, reaching $1.38 price per share at the time.
LakeShore Biopharma Co Ltd represents 19.02 million in outstanding shares, while the company has a total market value of $26.33 million with the latest information. LSB stock price has been found in the range of $0.96 to $1.48.
If compared to the average trading volume of 19.75K shares, LSB reached a trading volume of 15234296 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about LakeShore Biopharma Co Ltd [LSB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LSB shares is $52.03 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LSB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Trading performance analysis for LSB stock
LakeShore Biopharma Co Ltd [LSB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.29. With this latest performance, LSB shares gained by 38.14% in over the last four-week period, additionally sinking by -61.77% over the last 6 months – not to mention a drop of -60.12% in the past year of trading.
An analysis of Institutional ownership at LakeShore Biopharma Co Ltd [LSB]
There are presently around $7.59%, or 40.68% of LSB stock, in the hands of institutional investors.
